The results came after the close of the market hours. Shares of Sanofi Consumer Healthcare India Ltd ended at ₹4,940.00, down ...

Sanofi is racing to raise the flag on meningitis awareness—literally. | This year's 24 Hours of Le Mans endurance car race in ...

Six months after entering talks with U.S. private equity firm Clayton, Dubilier & Rice (CD&R), Sanofi has closed a deal to ...

Mumbai: Sanofi Consumer Healthcare India Ltd. has announced the company's Q1 results with Profit After Tax (PAT) at Rs 500 ...

Sanofi Consumer Healthcare India (SCHIL) reported a 20.25% year-on-year (YoY) decline in net profit to Rs 50 crore for the quarter ended 31 March 2025, compared to Rs 62.70 crore in the same period ...

Godrej Properties kicked off Q4 results season with strong guidance today. Shares of Godrej Agrovet, Phoenix Mills, and Indus ...

Dr Reddy’s Laboratories on Monday said it has expanded its strategic partnership with French biopharma giant Sanofi’s Indian ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron ...

Dr Reddy’s and Sanofi partner to launch Beyfortus, a novel drug to prevent respiratory syncytial virus in infants.

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) has issued an update. Sanofi Consumer Healthcare India Limited has published its ...

EconoTimes is a global, independent publication that delivers comprehensive news, analysis, and insights on the economy, finance, and markets. Based in Korea, we offer a unique perspective on global ...

Under the agreement, Dr Reddy's will have exclusive rights from SHIPL to promote and distribute Beyfortus within the country ...